Nexalin Technology Files S-1 Registration

TL;DR

Nexalin Tech just filed an S-1, looks like they're gearing up to go public.

AI Summary

Nexalin Technology, Inc., incorporated in Delaware, filed an S-1 registration statement on May 23, 2024. The company, operating in the electromedical and electrotherapeutic apparatus sector, is based in Houston, Texas, with its principal executive offices at 1776 Yorktown, Suite 550. The filing indicates a registration number of 333-[●] and an IRS Employer Identification No. of 27-5566468.

Why It Matters

This S-1 filing is a crucial step for Nexalin Technology, Inc. as it signals their intent to offer securities to the public, potentially raising capital and increasing their visibility in the market.

Risk Assessment

Risk Level: medium — As an S-1 filing, it represents a company in the process of going public, which inherently carries risks associated with market reception and regulatory scrutiny.

Key Numbers

• 333-[●] — Registration Number (Indicates the registration number for the S-1 filing.)
• 27-5566468 — IRS EIN (Company's Employer Identification Number.)

Key Players & Entities

• Nexalin Technology, Inc. (company) — Registrant
• Mark White (person) — Chief Executive Officer
• Martin S. Siegel (person) — Legal Counsel (Warshaw Burstein, LLP)
• Andrew M. Tucker (person) — Legal Counsel (Nelson Mullins Riley & Scarborough LLP)
• 333-[●] (dollar_amount) — Registration Number
• 27-5566468 (dollar_amount) — IRS Employer Identification No.

FAQ

Key Financial Figures

• $7,000,000 — CTUS NEXALIN TECHNOLOGY, INC. Up to $7,000,000 of Common Stock We are offering on a
• $0.001 — s up to $7,000,000 of our common stock, $0.001 par value per share. We are offering ea
• $1.14 — daq Capital Market on May 22, 2024, was $1.14 per share. We are an “emerging g
• $5,783 — ASC 810”), the Company recognized $5,783 of equity method investment income from
• $101,783 — pany had an Equity Method Investment of $101,783 and $96,000, respectively, recorded on
• $96,000 — quity Method Investment of $101,783 and $96,000, respectively, recorded on the condense
• $104,000 — quity Method Investment. Wider invested $104,000. In accordance with ASC 323, the Compan

Filing Documents

• nexalintech_s1.htm (S-1) — 644KB
• nexalin_ex5-1.htm (EX-5.1) — 9KB
• nexalin_ex23-1.htm (EX-23.1) — 2KB
• nexalin_ex107.htm (EX-FILING FEES) — 26KB
• img_001.jpg (GRAPHIC) — 7KB
• ex5-1_001.jpg (GRAPHIC) — 4KB
• 0001829126-24-003705.txt ( ) — 698KB

RISK FACTORS

RISK FACTORS 17 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA 52

USE OF PROCEEDS

USE OF PROCEEDS 54 DIVIDEND POLICY 55 CAPITALIZATION 56

DESCRIPTION OF SECURITIES

DESCRIPTION OF SECURITIES 58 PLAN OF DISTRIBUTION 61 LEGAL MATTERS 66 EXPERTS 66 WHERE YOU CAN FIND ADDTIONAL INFORMATION 66 INCORPORATION OF CERTAIN INORMATION BY REFERENCE 67 You should rely only on the information contained in this prospectus or any prospectus supplement or amendment. Neither we, nor the Placement Agent, have authorized any other person to provide you with information that is different from, or adds to, that contained in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. Neither we nor the Placement Agent take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. You should assume that the information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date. We are not making an offer of any securities in any jurisdiction in which such offer is unlawful. No action is being taken in any jurisdiction outside the United States to permit a public offering of our securities or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this public offering and the distribution of this prospectus applicable to that jurisdiction. i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (“SEC”). It omits some of the information contained in the registration statement and reference is made to the registration statement for further information with regard to us and the securities being offered hereby. You sho

View Full Filing

View this S-1 filing on SEC EDGAR